Unknown

Dataset Information

0

Targeted pathological collagen delivery of sustained-release rapamycin to prevent heterotopic ossification.


ABSTRACT: Heterotopic ossification (HO) in connective tissues like tendons and ligaments severely damages tissue structure. The pathogenesis of HO remains unclear but may involve mTOR. The results presented here indicate that tendon stem/progenitor cells do not undergo osteochondrogenic differentiation when mTOR signaling is inactivated by gene knockout or rapamycin (RAPA) treatment. Meanwhile, it is necessary to deliver RAPA to the injured sites and avoid disturbing the normal tendon. A RAPA delivery system, developed using collagen hybrid peptide (CHP) to modify the surface of poly(lactic-co-glycolic acid) (PLGA) nanoparticles, targeted RAPA specifically to pathological tendon collagen. The CHP-PLGA-RAPA nanoparticles showed excellent pathological collagen affinity, sustained-release ability, and bioactivity. In a mouse model of tendon HO, CHP-PLGA-RAPA nanoparticles specifically bound to pathological tendon and strongly suppressed HO progression. The mTOR signaling pathway appears to be a viable therapeutic target for tendon HO, and CHP-PLGA nanoparticles may be valuable for the treatment of tendon-related diseases.

SUBMITTER: Chen Y 

PROVIDER: S-EPMC7239699 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeted pathological collagen delivery of sustained-release rapamycin to prevent heterotopic ossification.

Chen Yangwu Y   Shen Weiliang W   Tang Chenqi C   Huang Jiayun J   Fan Chunmei C   Yin Zi Z   Hu Yejun Y   Chen Weishan W   Ouyang Hongwei H   Zhou Yiting Y   Mao Zhengwei Z   Chen Xiao X  

Science advances 20200429 18


Heterotopic ossification (HO) in connective tissues like tendons and ligaments severely damages tissue structure. The pathogenesis of HO remains unclear but may involve mTOR. The results presented here indicate that tendon stem/progenitor cells do not undergo osteochondrogenic differentiation when mTOR signaling is inactivated by gene knockout or rapamycin (RAPA) treatment. Meanwhile, it is necessary to deliver RAPA to the injured sites and avoid disturbing the normal tendon. A RAPA delivery sys  ...[more]

Similar Datasets

| S-EPMC10550814 | biostudies-literature
| S-EPMC9579182 | biostudies-literature
2022-04-01 | PXD030478 | Pride
| S-EPMC6478587 | biostudies-literature
| S-EPMC7774600 | biostudies-literature
2024-05-05 | GSE237512 | GEO
| S-EPMC7245788 | biostudies-literature
| S-EPMC6848966 | biostudies-literature
| S-EPMC5529164 | biostudies-literature
| S-EPMC6895226 | biostudies-literature